Pretreatment Hemoglobin Adds Prognostic Information To The NCCN-IPI In Patients With Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Containing Chemotherapy

Autor: Clausen MR, Maurer MJ, Ulrichsen SP, Larsen TS, Himmelstrup B, Rønnov-Jessen D, Link BK, Feldman AL, Slager SL, Nowakowski GS, Thompson CA, Pedersen PT, Madsen J, Pedersen RS, Gørløv JS, Cerhan JR, Nørgaard M, D'Amore F

Publikováno v: Clinical Epidemiology, Vol Volume 11, Pp 987-996 (2019)

Michael R Clausen,1 Matthew J Maurer,2 Sinna Pilgaard Ulrichsen,3 Thomas S Larsen,4 Bodil Himmelstrup,5 Dorthe Rønnov-Jessen,6 Brian K Link,7 Andrew L Feldman,8 Susan L Slager,2 Grzegorz S Nowakowski,9 Carrie A Thompson,9 Per Trøllund Pedersen,10 J

Externí odkaz: https://doaj.org/article/4db9c2ba43f34d2680109c2ee3bfaef9

Real-world outcomes following third or subsequent lines of therapy: A Danish population-based study on 189 patients with relapsed/refractory large B-cell lymphomas.

Autor: Al-Mashhadi AL; Department of Haematology, Clinical Cancer Research Centre, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.; Department of Haematology, Aarhus University Hospital, Aarhus, Denmark., Jakobsen LH; Department of Haematology, Clinical Cancer Research Centre, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.; Department of Mathematical Sciences, Aalborg University, Aalborg, Denmark., Brown P; Department of Haematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Gang AO; Department of Haematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Thorsteinsson AL; Department of Haematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Rasoul K; Department of Haematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Haissman JM; Department of Haematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Department of Haematology, Zealand University Hospital, Roskilde, Denmark., Tøstesen MB; Department of Haematology, Aarhus University Hospital, Aarhus, Denmark., Christoffersen MN; Department of Haematology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark., Jelicic J; Department of Haematology, Vejle Hospital, Vejle, Denmark., Jørgensen JB; Department of Internal Medicine, Haematology Section, Goedstrup Hospital, Herning, Denmark., Thomsen T; Department of Internal Medicine, Haematology Section, Goedstrup Hospital, Herning, Denmark., Dessau-Arp A; Department of Haematology, Hospital South West Jutland, Esbjerg, Denmark., Andersen APH; Department of Hematology, Hospital of Southern Jutland, Sønderborg, Denmark., Frederiksen M; Department of Hematology, Hospital of Southern Jutland, Sønderborg, Denmark., Pedersen PT; Department of Haematology, Hospital South West Jutland, Esbjerg, Denmark., Clausen MR; Department of Haematology, Vejle Hospital, Vejle, Denmark., Jørgensen JM; Department of Haematology, Aarhus University Hospital, Aarhus, Denmark., Poulsen CB; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Department of Haematology, Zealand University Hospital, Roskilde, Denmark., El-Galaly TC; Department of Haematology, Clinical Cancer Research Centre, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark., Larsen TS; Department of Haematology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.

Publikováno v: British journal of haematology [Br J Haematol] 2024 Mar; Vol. 204 (3), pp. 839-848. Date of Electronic Publication: 2023 Nov 27.

The Danish National Multiple Myeloma Registry

Autor: Gimsing P, Holmström MO, Klausen TW, Andersen NF, Gregersen H, Pedersen RS, Plesner T, Pedersen PT, Frederiksen M, Frølund U, Helleberg C, Vangsted A, de Nully Brown P, Abildgaard N

Publikováno v: Clinical Epidemiology, Vol Volume 8, Pp 583-587 (2016)

Peter Gimsing,1 Morten O Holmström,2 Tobias Wirenfelt Klausen,3 Niels Frost Andersen,4 Henrik Gregersen,5 Robert Schou Pedersen,6 Torben Plesner,7 Per Trøllund Pedersen,8 Mikael Frederiksen,9 Ulf Frølund,2 Carsten Helleberg,3 Annette Vangsted,1 Pe

Externí odkaz: https://doaj.org/article/b1595f374813485dacfe63b1e1f1f473

Patients in complete remission after R-CHOP(-like) therapy for diffuse large B-cell lymphoma have limited excess use of health care services in Denmark.

Autor: Jakobsen LH; Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark. lasse.j@rn.dk.; Department of Clinical Medicine, Aalborg University, Alborg, Denmark. lasse.j@rn.dk., Øvlisen AK; Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Alborg, Denmark., Severinsen MT; Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Alborg, Denmark., Bæch J; Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark., Kragholm KH; Unit of Clinical Biostatistics and Epidemiology, Aalborg University Hospital, Aalborg, Denmark.; Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark., Glimelius I; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.; Department of Immunology, Genetics and Pathology, Unit of Oncology, Uppsala University, Uppsala, Sweden., Gang AO; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Jørgensen JM; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark., Frederiksen H; Department of Hematology, Odense University Hospital, Odense, Denmark., Poulsen CB; Department of Hematology, Zealand University Hospital, Roskilde, Denmark., Clausen MR; Department of Hematology, Vejle Sygehus, Vejle, Denmark., Pedersen PT; Department of Hematology, Sydvestjysk sygehus, Esbjerg, Denmark., Pedersen RS; Department of Medicine, Holstebro sygehus, Holstebro, Denmark., Torp-Pedersen C; Department of Cardiology, Nordsjællands Hospital, Hillerød, Denmark.; Department of Public Health, University of Copenhagen, Copenhagen, Denmark., Eloranta S; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden., El-Galaly TC; Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Alborg, Denmark.

Publikováno v: Blood cancer journal [Blood Cancer J] 2022 Jan 27; Vol. 12 (1), pp. 16. Date of Electronic Publication: 2022 Jan 27.

Validation of the UK myeloma research alliance risk profile, a new clinical prediction model for outcome in patients with newly diagnosed multiple myeloma not eligible for autologous stem cell transplantation; a population-based study from the Danish national multiple myeloma registry.

Autor: Redder L; Department of Haematology, Odense University Hospital, Odense, Denmark., Klausen TW; Department of Haematology, Herlev Hospital, Herlev, Denmark., Vangsted AJ; Department Haematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark., Gregersen H; Department of Haematology, Aalborg University Hospital, Aalborg, Denmark., Andersen NF; Department of Haematology, Aarhus University Hospital, Aarhus, Denmark., Pedersen RS; Department of Haematology, Holstebro Hospital, Holstebro, Denmark., Szabo AG; Department of Haematology, Vejle Hospital, Vejle, Denmark., Frederiksen M; Department of Haematology, Hospital of Southern Jutland, Aabenraa, Denmark., Frølund UC; Department of Haematology, Zealand University Hospital, Roskilde, Denmark., Helleberg C; Department of Haematology, Herlev Hospital, Herlev, Denmark., Nielsen LK; Department of Haematology, Odense University Hospital, Odense, Denmark.; Department of Internal Medicine and Cardiology, Regional Hospital Viborg, Denmark., Pedersen PT; Department of Haematology, South-Western Hospital, Esbjerg, Denmark., Salomo M; Department Haematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark., Gimsing P; Department Haematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark., Frederiksen H; Department of Haematology, Odense University Hospital, Odense, Denmark.; Academy of Geriatric Cancer Research (AgeCare), Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark., Abildgaard N; Department of Haematology, Odense University Hospital, Odense, Denmark.; Academy of Geriatric Cancer Research (AgeCare), Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.

Publikováno v: British journal of haematology [Br J Haematol] 2021 Apr; Vol. 193 (1), pp. 119-124. Date of Electronic Publication: 2020 Jun 09.